Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

U.S. to Invest $70 Million to Boost Access to COVID-19 Tests

By Reuters Staff | on October 29, 2021 | 0 Comment
Uncategorized
  • Tweet
  • Email
Print-Friendly Version

The Biden administration said it will invest $70 million to boost the availability and lower costs of rapid, over-the-counter COVID-19 tests in the United States, as it looks to ease a nationwide shortage that drove up testing costs.

You Might Also Like
  • U.S. Awards $100 Million to Health Centers to Boost Coronavirus Response
  • Rapid Antigen Tests Twice a Week May Be Enough to Catch New COVID-19 Cases
  • You Should Invest in Mutual Funds

High demand for the tests from U.S. employers amidst the Delta variant surge, especially with the U.S. government mandating large employers to have their workers inoculated and tested weekly, pushed up costs for state and local testing programs.

“Access to easy-to-use, affordable and reliable COVID tests is key to bringing peace of mind to our families, especially as we approach winter,” U.S. Department of Health and Human Services Secretary Xavier Becerra said on Oct. 25, 2021.

The National Institutes of Health (NIH) will invest $70 million and work with the U.S. Food & Drug Administration to help accelerate the review process to bring more tests to the U.S. market. The FDA is also streamlining its regulatory pathway for manufacturers developing over-the-counter at-home tests.

Separately, U.S. FDA said it has issued emergency use authorization to another rapid antigen test developed by Celltrion Diatrust, bringing the total number of rapid, at-home tests available to the public to 10.

The U.S. government has so far invested around $3 billion to procure rapid COVID-19 tests.

Topics: coronavirusCOVID-19Testing

Related

  • Masks: The Good, the Bad, and Systematic Reviews

    April 5, 2023 - 0 Comment
  • March News from the College

    March 2, 2023 - 0 Comment
  • New Patient Education Resources Available to Encourage COVID-19 Treatments

    February 9, 2023 - 0 Comment

Current Issue

ACEP Now May 03

Read More

No Responses to “U.S. to Invest $70 Million to Boost Access to COVID-19 Tests”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603